Develops drugs for neurodegenerative diseases like Alzheimer's and Parkinson's.
Jun 2026Revenue $13.9M/yrExpenses $140M/yr
No trendCash runway ≈ 1.1 years from Jun 2026
Figures by year
When will Alector be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $13.9M and expenses $140M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $21.0M | $177M | −$156M |
| Dec 2024 | $101M | $246M | −$145M |
| Dec 2023 | $97.1M | $249M | −$152M |
| Dec 2022 | $134M | $271M | −$138M |
| Dec 2021 | $207M | $244M | −$37.4M |
| Dec 2020 | $21.1M | $216M | −$195M |
| Dec 2019 | $21.2M | $136M | −$114M |
| Dec 2018 | $27.7M | $85.0M | −$57.3M |
| Dec 2017 | $3.73M | $36.4M | −$32.7M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.